Authors
Latest:
Creating Innovative Ways to Improve Alzheimer Disease Prevention: Miia Kivipelto, MD, PhDThe professor of clinical geriatric epidemiology at Karolinska Institutet discussed strategies for lowering the risk of Alzheimer disease, and the new ways to approach prevention. [WATCH TIME: 4 minutes]
Latest:
Acceptance of and Access to Biosimilars and Generics: The MS Treatment Landscape and Patient EngagementWith the first approved biosimilar entering the US treatment market, the time for clinicians to understand the coming era of therapies is now.
Latest:
Expanding the Genetic Pool of Non-European Populations in Parkinson Disease: Ignacio Mata, PhDThe associate professor of neurology at the Cleveland Clinic Lerner Institute provided insight on a recently published meta-analysis identifying independent genome-wide significant loci whose expression is associated with Parkinson disease risk. [WATCH TIME: 5 minutes]
Latest:
Looking Ahead at MS Treatment and Closing Thoughts on BiosimilarsJeffrey Cohen, MD; Sarah Anderson, PharmD, NBC-HWC; and Alicyn Magruder, PharmD, BCACP, MSCS, share their final thoughts on the future landscape of clinical MS care in the biosimiliars era. [WATCH TIME: 12 minutes]
Latest:
Diagnosing Alzheimer Disease With New Blood Tests in Primary Care Settings: Sebastian Palmqvist, MD, PhDThe associate professor of neuroscience at Lund University in Sweden discussed findings from a study of a new blood test examining biomarkers which demonstrated a high accuracy in identifying Alzheimer disease pathology. [WATCH TIME: 5 minutes]
Latest:
Reassessing the Process of Drug Development for Duchenne Muscular Dystrophy: Dongzhe Hong, PhDThe postdoctoral research fellow at Brigham and Women’s Hospital and Harvard Medical School discussed some of the issues with ensuring timely care access to approved therapies for patients with Duchenne muscular dystrophy. [WATCH TIME: 3 minutes]
Latest:
Michael Okun, MD: Long-Term Plan for Modifying Neurologic Device Approval SystemThe executive director of the Norman Fixel Institute for Neurological Diseases gave his call-to-action on how to change the approval system for neurologic devices for rare diseases.
Latest:
Increased Risk of Insomnia in Transgender Youths With Mental Health Disorders: Ronald Gavidia, MD, MSThe clinical assistant professor in the division of Sleep Medicine, Department of Neurology, University of Michigan spoke about the associations of mental health with insomnia in transgender youth. [WATCH TIME: 5 minutes]
Latest:
Switching MG Treatment Due to Adverse Events or Poor Disease ControlExpert neurologists share approaches to switching MG treatment due to either poor disease control or adverse events.
Latest:
Practice Pearls for Management of NMOSDExperts in neurology discuss immune tolerance as an alternative strategy and share practice pearls for approaching treatment of NMOSD.
Latest:
The Need to Find Valuable Parkinson Disease Biomarkers: Mark Lew, MDThe director of the Division of Movement Disorders at the USC Keck School of Medicine discussed the early reactions behind reflex tears as a potential biomarker for Parkinson disease. [WATCH TIME: 2 minutes]
Latest:
Future Directions for the Management of NarcolepsyMargaret Park, MD, and Russell Rosenberg, PhD, DABSM, provide clinical pearls and the future treatment landscape for the management of narcolepsy.v
Latest:
Improving Access to Stroke Systems of Care: Mitchell S.V. Elkind, MD, MS, MPhilThe president of the American Heart Association discussed the necessary steps to increase access to systems of care in order to improve health overall, including the integration of telemedicine.
Latest:
Cure CMD: Benefits of the Biennial SciFam ConferenceRachel Alvarez and Gustavo Dziewczapolski, PhD, of Cure CMD spoke about the benefits of attending the biennial Scientific & Family Conference to learn more about congenital muscle diseases and interact with the patient community.
Latest:
Emerging Concepts in Migraine and Targeting PACAP: Dolores Santamaria, MDThe director of the Headache Center at Allegheny Health Network provided an overview of clinically relevant approaches to treat migraine at its core pathology. [WATCH TIME: 2 minutes]
Latest:
Sleeping Around the Podcast: Living with Narcolepsy & Cataplexy: The Patient's PerspectiveSleeping Around the Podcast is joined by Rachel Nesmith, a patient with narcolepsy, who shares her story of overcoming the burdens and impairments of living with narcolepsy and cataplexy.
Latest:
AUPN 2022 Veterans Health Administration WorkshopGlenn Graham, MD, PhD; and Sharyl Martini, MD, PhD, moderate a discussion with 4 clincial experts to advance specialized clinical care, education and research for Veterans with movement disorders, multiple sclerosis, epilepsy and seizures, and headache. [WATCH TIME: 1 hour, 52 minutes]
Latest:
Finding Positivity Through Adversity in Poststroke Care: Harmony Sierens, MDThe medical director of the Inpatient Rehabilitation Unit at Ascension Genesys Hospital discussed the importance of early intervention, sustained care, and rehabilitation in managing poststroke patients. [WATCH TIME: 4 minutes]
Latest:
Peers & Perspectives: The Induction vs Escalation Approach to MS and the TREAT-MS TrialScott Newsome, DO, and Ellen Mowry, MD, discuss the ongoing TREAT-MS trial and its goals, the importance of the findings for clinical practice in multiple sclerosis, and the ongoing discussion around induction vs escalation in MS treatment. [WATCH TIME: 24 minutes]
Latest:
Key Takeaways and Future Opportunities for WVE-004: Michael Panzara, MD, MPHThe chief medical officer of Wave Life Sciences outlined the FOCUS-C9 study, which has incorporated feedback from patients with both ALS and FTD, as well as investigators in the research field.
Latest:
Stephen Cunnane, PhD: Evaluating Ketogenics in Brain Energy RescueThe professor from the Universite de Sherbrooke discusses the use of ketogenic diets and supplements to increase cognition.
Latest:
Future Research Directions for DCTclock and the Potential to Predict Alzheimer Biomarkers: Ali Jannati, MD, PhDThe manager of Clinical Development-Research at Linus Health discussed potential avenues of research for the DCTclock and expanding its capabilities as a potential detector of cognitive decline. [WATCH TIME: 3 minutes]
Latest:
Building a Large-Scale Database of Genetic Associations to Alzheimer Disease: Margaret Pericak-Vance, PhDThe director of the John P. Hussman Institute for Human Genomics at the University of Miami detailed a new international initiative that expands on the genetic backgrounds of people of Hispanic and African ancestry. [WATCH TIME: 4 minutes]
Latest:
Expanding Research of Sleep and Cognitive Risks Associated: Christian Agudelo, MDThe Evelyn F. McKnight Neurocognitive Scholar at the University of Miami Miller School of Medicine discussed observing how sleep may impact cognitive decline in different populations.
Latest:
Evaluating 3K3A-APC in Patients With ALS: Kent Pryor, PhDThe CEO of ZZ Biotech outlined the design of the phase 2 trial of 3KA-APC, which will enroll 16 patients with amyotrophic lateral sclerosis. [WATCH TIME: 4 minutes]
Latest:
Incorporation of Registered Dietitians in MS Care: Tyler Titcomb, PhD, RDN, IFMCPThe postdoctoral scholar at the University of Iowa commented on why the multiple sclerosis field should lean on registered dietitians to help alleviate symptoms of patients with multiple sclerosis. [WATCH TIME: 2 minutes]
Latest:
Let’s Get Moving: A Multidisciplinary Approach to Gait Rehabilitation in Multiple SclerosisCurrent research pushes to advance therapeutic possibilities and understand underlying neural mechanisms for gait impairments in individuals with the disease.
Latest:
Muscular Dystrophy Association: A Hybrid Conference Featuring the Latest Advances in Neuromuscular Research, Therapy, and Clinical CareThe Muscular Dystrophy Association's annual meeting will take place in-person and virtually in Nashville, Tennessee, on March 13-16, with more than 950 in-person attendees and 130 presenters.
